Crystal structure of the Pl 3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes

Nature Structural Biology

Volumn 3, Issue 4, 1996, Pages 364-374

  Nolte, R T ^a,b   Eck, M J ^a,b   Schlessinger, J ^c   Shoelson, S E ^b,d   Harrison, S C ^a,e  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d JOSLIN DIABETES CENTER   (United States)

^e HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPEPTIDE; PROTEIN SUBUNIT;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CELL GROWTH; CRYSTAL STRUCTURE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINO ACID SEQUENCE; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; HUMANS; METHIONINE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHOSPHOPEPTIDES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN BINDING; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SRC HOMOLOGY DOMAINS;

EID: 0029878266     PISSN: 10728368     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Kapeller, R. & Cantley, L.C. Phosphatidylinositol 3-kinase. Bioessays 16, 565-576 (1994).
2. Yao, R. & Cooper, G.M. Requirement for phosphatidyinositol-3 kinase in the prevention of apotosis by nerve growth factor. Science 267, 2003-2005 (1995).
3. Skolnik, E.Y. et al. Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases. Cell 65, 83-90 (1991).
4. Otsu, M. et al. Characterization of two 85 kD proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes and PI3-kinase. Cell 65, 91-104 (1991).
5. Escobedo, J.A. et al. cDNA cloning of a novel 85 kD protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF b-receptor. Cell 65, 75-82 (1991).
6. Klippel, A., Escobedo, J.A., Hu, Q. & Williams, L.T. A region of the 85-kda subunit of phosphatidylinositol 3-kinase binds the 110-kda catalytic subunit in vivo. Mol. Cell. Biol. 13, 5560-5566 (1994).
7. Dhand, R. et al. PI 3-kinase - structural and functional analysis of intersubunit interactions. Embo J. 13, 511-521 (1994).
8. Hu, P., Mondino, A., Skolnik, E.Y. & J., S. Cloning of a novel ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85. Mol. Cell. Biol. 13, 7677-7688 (1993).
9. Soltoff, S.P., Carraway, K.L., Prigent, S.A., Gullick, W.G. & Cantley, L.C. ErbB3 is involved in activation of phosphatidyinositol 3-kinase by epidermal growth factor. Mol. Cell. Biol. 14, 3550-3558 (1994).
10. Lev, S., Givol, D. & Yarden, Y. Interkinase domain of kit contains the binding site for phosphatidylinositol 3′ kinase. Proc. Natl. Acad. Sci. USA 89, 678-682 (1992).
11. Reedijk, M. et al. Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3′-kinase SH2 domains: a model for SH2-mediated receptor-target interactions. Embo J. 11, 1365-1372 (1992).
12. Sun, X.J. et al. The structure of the insulin receptor substrate IRS-1 defines a unique signal transdurtion protein. Nature 352, 73-77 (1991).
13. Prasad, K.V.S. et al. T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic pTyr-Met-Xxx-Met motif. Proc. Natl. Acad. Sci. USA 91, 2834-2838 (1994).
14. Auger, K.R., Carpenter, C.L., Shoelson, S.E., Piwnica-Worms, H. & Cantley, L.C. Polyoma virus middle T antigen/pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro:dependence on protein-tyrosine kinase activity. J Biol. Chem. 267, 5408-5415 (1992).
15. Cantley, L.C. et al. Oncogenes and signal transdurtion. Cell 64, 281-302 (1991).
16. Songyang, Z. et al. SH2 domains recognize specific phosphopeptide sequences. Cell 72, 767-778 (1993).
17. Piccione, E. et al. PI 3-kinase p85 SH2 domains specificity defined by direct phosphopeptide/SH2 domain binding. Biochemistry 31, 3197-3202 (1993).
18. Songyang, Z. et al. Specific motifs recognized by the SH2 domains of Csk 3BP2, fps/fes, Grb-2, HCP, SHC, Syk and Vav. Mol. Cell. Biol. 14, 2777-2785 (1994).
19. Booker, G.W. et al. Structure of SH2 domain of the p85α subunit of phosphatidylinositol-3-OH kinase. Nature 358, 684-687 (1992).
20. lck. Nature 362, 87-91 (1993).
21. Hatada, M.H., et al. Molecular basis for the interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor. Nature 377, 32-38 (1995).
22. Lee, C.H. et al. Crystal structures of peptide complexes of the N-terminal SH2 domain of the Syp tyrosine phosphatase. Structure 2, 423-438 (1994).
23. Pascal, S.M. et al. Nuclear magnetic resonance structure of an SH2 domain of PLC complexed with a high affinity binding peptide. Cell 77, 461-472 (1994).
24. Overduin, M., Rios, C.B., Mayer, B.J., Baltimore, D. & Cowburn, D. Three-Dimensional Solution Structure of the src Homology 2 Domain of c-abl. Cell 70, 697-704 (1992).
25. Waksman, G. et al. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine phosphorylated peptides. Nature 358, 646-653 (1992).
26. Waksman, G., Shoelson, S.E., Pant, N., Cowburn, D. & Kuriyan, J. Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: Crystal structures of the complexed and peptide-free forms. Cell 72, 779-790 (1993).
27. Zhou, M.M. et al. Solution structure of the She SH2 domain complexed with a tyrosine-phosphorylated peptide from the T-cell receptor. Proc. Natl. Acad. Sci. USA 92, 7784-7788 (1995).
28. Eck, M.J., Atwell, S.K., Shoelson, S.E. & Harrison, S.C. Crystal structure of the regulatory domains of the Src-family tyrosine kinase p56lck. Nature 368, 764-769 (1994).
29. Panayotou, G. et al. Interaction of the p85 subunit of PI 3-kinase and its N-terminal SH2 domain with a PDGF receptor phosphorylation site: structural features and analysis of conformational changes. Embo J. 11, 4261-4272 (1992).
30. Shoelson, S.E. et al. Specific phosphopeptide binding regulates a conformational change in the PI 3-kinase SH2 domain associated with enzyme activation. Embo J. 12, 795-802 (1993).
31. Williams, K.P. & Shoelson, S.E. A photoaffinity scan maps regions of the p85 SH2 domain involved in phosphoprotein binding. J. Biol. Chem. 268, 5362-5364 (1993).
32. Hensmann, M. et al. Phosphopeptide binding to the N-terminal SH2 domain of of the p85a subunit of PI 3-kinase: A heteronuclear NMR study. Prof. Sci. 3, 1020-1028 (1994).
33. Waksman, G. et al. Crystal structrue of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature 358, 646-653 (1992).
34. Eck, M.J., Pluskey, S., Trub, T., Harrison. S.C. & Shoelson, S.E. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2. Nature 349, 277-280 (1996).
35. Songyang, Z., Gish, G., Mbamalu, G., Pawson, T. & Cantley, L.C. A single point mutation switches the specificity of group III Src homology (SH) 2 domains to that of group I SH2 domains. J. Biol. Chem. 270, 26029-26032 (1995).
36. Mahadevan, D. et al. Comparison of calcium-dependent co nformational changes in the N-terminal SH2 domains of p85 and GAP defines distinct properties for SH2 domains. Biochemistry 33, 746-754 (1994).
37. Backer, J.M. et al. Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. Embo J. 11, 3469-3479 (1992).
38. Carpenter, C.L. et al. Phosphoinositide 3-kinase is activated by phosphopeptides that bind to the SH2 domains of the 85 kDa subunit. J. Biol. Chem. 268, 9478-9483 (1993).
39. Herbst, J.J. et al. Potent activation of phospahatidylinositol 3-kinase by simple phosphotyrosine peptides derived from insulin receptor substrate 1 containing two YMXM motifs for binding SH2 domains. Biochemistry 33, 9376-9381 (1994).
40. Marengere, L.E.M. et al. SH2 domain specificity and activity modified by a single residue. Nature 369, 502-505 (1994).
41. Sambrook, J., Fritsch, E. & Maniatis, T. Molecular Cloning: A laboratory manual (Cold Spring Harbor Laboratory Press, 1989).
42. Hendrickson, W.A., Horton, J.R. & LeMaster, D.M. Selenomethionyl proteins produced for analysis by multiwavelength anonomalous diffraction (MAD): a vehicle for direct determination of three-dimensional structure. EMBO J. 9, 1665-1672 (1990).
43. Kabsch, W. Evaluation of single crystal diffraction data from a position sensitive detector. J. Appl. Crystallogr. 21, 916-924 (1988).
44. CollaborativeComputationalProjectNumber4. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr. D50, 760-776 (1994).
45. Otwinowski, Z. Maximun likelihood refinement of heavy atom parameters (1991).
46. Cowtan, K. "DM": an automated procedure for phase improvement by density modification. Joint CCP4 and ESF-EACBM Newsletter on Protein Crystallography 31, 34-38 (1994).
47. Jones, T.A., Zou, J.Y., Cowan, S. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta. Crystallogr. A47, 110-119 (1991).
48. Brünger, A. X-PLOR Version 3.0: A System for Crystallography and NMR (Yale University Press, New Haven, 1992).
49. Navaza, J. in Molecular Replacement: Proceedings of the CCP4 Study Weekend (eds. Dodson, E.J., Gover, S. & Wolf, W.) 87-90 (SERC, Daresbury, UK. 1992).
50. Kraulis, P.J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950 (1991).
51. Nicholls, A., Sharp, K.A. & Honig, B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins Struct. Funct. Genet. 11, 281-296 (1991).